CPT code 67415 represents a percutaneous needle biopsy of the orbit used to obtain tissue from suspicious lesions in the bony cavity that contains the eye. As a focused diagnostic procedure, orbital needle biopsy provides tissue for histopathologic and microbiologic evaluation and can be critical to distinguishing benign from malignant or infectious processes that affect vision and ocular structures. Nationally, this code is relevant to ophthalmology, oculoplastics, and head and neck surgical practices, as well as facilities that perform outpatient surgical diagnostics.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find context on clinical use, typical sites of service, common billing modifiers, and the policy and reimbursement landscape as it relates to orbital diagnostic procedures. The publication highlights procedural intent, common clinical indications, coding nuances for outpatient settings, and areas where payers commonly apply medical necessity review.

This summary equips clinicians, coding professionals, and policy stakeholders with an understanding of CPT code 67415’s clinical role, expected settings of care, and the payer mix likely to process claims for this service. Data not available in the input is noted where specific benchmarks, ICD-10 linkage, and provider taxonomies would normally appear.